The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
Two physicians argue that disaster preparedness for bioterrorist attacks diverts health care resources from other critical medical and public health needs.
Physicians of patients who request physician-assisted suicide should not avoid the subject and should try to discuss the patients' specific concerns and fears with them.
Physicians of patients who request physician-assisted suicide should not avoid the subject and should try to discuss the patients' specific concerns and fears with them.
A centralized registry to provide information to consumers regarding the effectiveness of clinical trials is needed to help patients make informed decisions about treatment.